Standard BioTools sells microfluidics business to ARCHIMED; amount not disclosed

Standard BioTools has sold its microfluidics business to ARCHIMED, according to a report. The transaction amount was not disclosed.

Detected & updated continuously · Source: Nebula

Story subjects

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula